In a new study, researchers have been able to show differences in how Rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphatic leukemia. This has awakened hopes that this analysis method could pave the way for important breakthroughs in immunotherapy research and treatment.
source https://www.sciencedaily.com/releases/2020/12/201211100617.htm
Monday, 14 December 2020
Related Posts
Envy coupled with competition divides society into an upper and lower class, game theoretical study shows
Study evaluates stress level of rehabilitated sea turtles during transport
Adolescents from disadvantaged neighborhoods show gene regulation differences
Is Santa real? Examining children's beliefs in cultural figures and 'non-real' people
The rate we acquire genetic mutations could help predict lifespan, fertility
Discovery allows 3D printing of sensors directly on expanding organs
0 comments: